Ambience Healthcare

Vertical AI (legal, health, finance) · https://www.ambiencehealthcare.com

Verdict: Hold · Confidence: medium · Reviewed 2026-10-15

Ambience Healthcare sells ambient documentation, coding, and CDI software and raised a $243 million Series C on July 29, 2025, co-led by Oak HC/FT and Andreessen Horowitz. Named live customers include Cleveland Clinic, UCSF Health, Houston Methodist, and Memorial Hermann. The company release does not state revenue or a valuation.

Rubric

DimensionScore (1–5)Notes & sources
Real customers & revenue quality
Are there named paying customers, recurring revenue, and retention evidence?
3/5
The Series C release names Cleveland Clinic, UCSF Health, Houston Methodist, and Memorial Hermann, and says the platform supports more than 100 specialties across outpatient, emergency, and inpatient settings. No revenue or customer-count total was stated on that page.
Unit economics
Do gross margins survive inference/compute costs? Is pricing durable?
UnknownUnknown — no public figure found.
Moat
Proprietary data, distribution, switching costs, or tech that is hard to copy?
3/5
Ambience integrates with Epic, Oracle Cerner, and athenahealth and cites a KLAS customer satisfaction score of 97.7 plus a third-party ROI validation tied to coding accuracy. The category is crowded with other ambient scribes.
Platform risk
Could a model provider or incumbent ship this as a feature? (higher score = lower risk)
3/5
The product is embedded in EHRs it does not own. Epic, Oracle Cerner, or a larger scribe vendor can compress the wedge. OpenAI's startup fund is an investor, which does not remove dependence on foundation models and EHR platforms.
Team & execution
Shipping cadence, leadership track record, stability.
4/5
Founded in 2020 by Mike Ng and Nikhil Buduma, the company expanded from ambient scribing to coding and CDI and closed $243 million with Oak HC/FT, a16z, the OpenAI Startup Fund, Kleiner Perkins, and Optum Ventures.
Funding vs. traction
Is capital raised justified by verifiable traction?
3/5
$243 million is a large round for a company that has not disclosed revenue. Named health-system deployments show a real product, but the round cannot be matched to a public ARR figure from the sources opened.
Hype signals
Demo-driven marketing, vague metrics, valuation outrunning evidence? (higher score = fewer red flags)
3/5
The release is specific about customers and a KLAS score. It also uses 'leading' language without a revenue disclosure, so the funding is ahead of the public financial evidence.

Listing source: https://www.ambiencehealthcare.com. Revenue, users, and valuation figures appear only when publicly sourced; otherwise they are marked unknown.